Corcept Therapeutics | CORT - Current Liabilities

Stock Price
32.32
Daily Change
0.17 0.53%
Monthly
-18.45%
Yearly
-42.30%
Q1 Forecast
31.18

Corcept Therapeutics reported $166.08M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
ANI Pharmaceuticals USD 278.11M 7.56M Dec/2025
Ardelyx USD 83.39M 1.67M Sep/2025
Assertio Holdings USD 166.78M 34.25M Sep/2025
Aurora Cannabis CAD 124.12M 32.76M Sep/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Canopy Growth CAD 81.1M 17.56M Sep/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Lexicon Pharmaceuticals USD 34.84M 75.86M Jun/2025
Merck USD 28.63B 2.59B Sep/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Novartis USD 32B 286M Sep/2025
Novartis USD 32B 286M Sep/2025
Omeros USD 85.5M 2.28M Jun/2025
Pacira USD 120.59M 13.51M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025